Ovid Therapeutics Inc. · NASDAQ:OVID
Balyasny Asset Management L.P.'s stake in Ovid Therapeutics Inc. fell to 4.99% (Schedule 13G/A)
Event Jun 30, 2026 · Filed Aug 14, 2026
Balyasny Asset Management L.P.'s stake in Ovid Therapeutics Inc. fell to 4.99%, 9,313,341 shares, as a passive investor on Jun 30, 2026. Filed Aug 14, 2026 (Schedule 13G/A).
- Stake
- 4.99%
- Shares
- 9,313,341
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 5 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| BALYASNY ASSET MANAGEMENT L.P. | 4.99% | 9,313,341 |
| BAM GP LLC | 4.99% | 9,313,341 |
| Balyasny Asset Management Holdings LP | 4.99% | 9,313,341 |
| Dames GP LLC | 4.99% | 9,313,341 |
| Dmitry Balyasny | 4.99% | 9,313,341 |
Source
Related
- Ovid Therapeutics Inc.
- Balyasny Asset Management L.P.
- Ovid Therapeutics Inc. shareholders
- Schedule 13G · Balyasny Asset Management L.P. · May 15, 2026
- Schedule 13G/A · Eventide Asset Management, LLC · Aug 14, 2026
- Schedule 13G/A · Ra Capital Management, L.P. · Aug 14, 2026
- Schedule 13G/A · ADAR1 Capital Management, LLC · Aug 14, 2026
- Schedule 13G/A · Affinity Asset Advisors, LLC · Aug 13, 2026
- Schedule 13G · BlackRock, Inc. · Jul 29, 2026